Evidence map›Paper›PMID 40816524›Full record

ArticleJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance

Mitral annular disjunction in Marfan syndrome: a multicenter cardiovascular magnetic resonance study.

Kenan Kaya, Jonathan Kottlors, Thorsten W Gietzen, Leon Bischoff, Jan M Brendel, Reza Dehdab, Moritz C Halfmann, Lukas Müller, Philipp V Stein, Lukas Goertz and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Kenan KayaInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Electronic address: kenan.kaya@uk-koeln.de.
Jonathan KottlorsInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Thorsten W GietzenDepartment III of Internal Medicine, Heart Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Leon BischoffDepartment of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Jan M BrendelDepartment of Radiology, Diagnostic and Interventional Radiology, University of Tübingen, Tübingen, Tübingen, Germany.
Reza DehdabDepartment of Radiology, Diagnostic and Interventional Radiology, University of Tübingen, Tübingen, Tübingen, Germany.
Moritz C HalfmannDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Lukas MüllerDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Philipp V SteinDepartment III of Internal Medicine, Heart Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Lukas GoertzInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Jan Paul JanßenInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Roman Johannes GertzInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Robert TerzisInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Vanessa SchmidtInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Kilian WeissPhilips GmbH Hamburg, Hamburg, Germany.
Christopher HohmannDepartment III of Internal Medicine, Heart Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
David MaintzInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Tilman EmrichDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; German Centre for Cardiovascular Research, Partner site Rhine-Main, Mainz, Germany; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, South Carolina, USA.
Patrick KrummDepartment of Radiology, Diagnostic and Interventional Radiology, University of Tübingen, Tübingen, Tübingen, Germany.
Julian A LuetkensDepartment of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Carsten H GietzenInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Lenhard PennigInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData on the prevalence of mitral annular disjunction (MAD) in Marfan syndrome (MFS) based on cardiovascular magnetic resonance (CMR) is sparse. The purpose of this study was to assess prevalence, extent, and distribution of MAD in MFS using CMR and to examine its association with left heart parameters, aortic dimensions, and cardiovascular events.

methodsThis retrospective multicenter study included CMR studies of patients treated for MFS at four tertiary care medical centers with a (likely) pathogenic fibrillin-1 gene variant. Two radiologists (5 and 8 years of experience in CMR) evaluated datasets for MAD (at 4 points around the annulus, including measurement of extent) and mitral valve prolapse (MVP). Further assessment comprised volumetric and functional analysis of the left ventricle (LV), left atrial size, and aortic root diameters. Cardiovascular events included aortic (aortic surgery or aortic dissection), arrhythmic (sustained ventricular tachycardia or sudden cardiac death), and mitral events (mitral valve surgery, MVS).

resultsAmong 91 patients [(28.9±14.0 years, 47.3% female (n = 43/91)]81.3% (n = 74/91) had MAD (extent: 6.1±2.6 mm). MAD was mostly found at the inferior insertion (72.5% of patients, n = 66/91) and usually affected all sites (39.6% of patients, n = 36/91). Left heart parameters and aortic dimensions did not differ between MAD and no MAD groups (P>0.05). MAD extent and localizations showed significant correlations with LV dilatation (e.g., inferior MAD: r=0.62 for end-diastolic volume index), decreased LV ejection fraction (e.g., anterolateral MAD: r=-0.46), and MVP (e.g., MAD distance: r=0.83), which was found in 44.6% of patients (n = 33/74) with MAD while only affecting 11.8% (n = 2/17) without MAD (P=0.017). Based on receiver operating characteristic analysis for the prediction of MVP prevalence, a threshold of 7.1 mm MAD extent was identified as the optimal cut-off value (sensitivity: 77.1%, specificity: 89.3%). Additionally, subgroup analysis applying different thresholds of MAD extent revealed a significantly larger displacement of MVP and LV volumes as well as higher aortic root z scores for a threshold of ≥8 mm. After a mean follow-up of 4.0±3.0years, cardiovascular events (aortic: n=13/91 [14.3%], arrhythmic: n= 2/91 [2.2%], and mitral: n=2/91 [2.2%] of patients) did not differ significantly (all P>0.05) between no MAD and MAD groups regardless of applied thresholds although MVS was observed exclusively in patients with MAD.

conclusionThe high prevalence, large extent, and predominantly pan-annular distribution of MAD suggest a systemic annular pathology in MFS. Overall presence of MAD was not associated with changes to left heart parameters, aortic dimensions, and cardiovascular events. However, MAD, taking into account its extent and affected insertion sites, could serve as a potential marker of disease progression given the shown association of localizations and distance with LV dysfunction and remodeling as well as aortic enlargement and the formation of MVP.

Indexed as

Magnetic Resonance Imaging, CineMarfan SyndromeMitral ValveMitral Valve ProlapseAdipokinesAdolescentAdultFemaleFibrillin-1Genetic Predisposition to DiseaseHumansMaleMiddle AgedPhenotypePredictive Value of TestsPrevalenceAdipokinesFBN1 protein, humanFibrillin-1Cardiovascular magnetic resonanceConnective tissue disorderMarfan syndromeMitral annular disjunctionMitral valve prolapse

Identifiers

PMID40816524
PMCPMC13265430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.